Kronos Bio, Inc. (KRON) Financial Statements (2026 and earlier)

Company Profile

Business Address 1300 S. EL CAMINO REAL
SAN MATEO, CA 94402
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:112,422172,997247,900339,500462,100
Cash and cash equivalent84,57164,32675,973198,270248,009
Short-term investments27,851108,671162,212141,239165,052
Other undisclosed cash, cash equivalents, and short-term investments   9,715(9)49,039
Prepaid expense   2,0643,1713,121
Disposal group, including discontinued operation 300400   
Other undisclosed current assets2,5065,381(5,673)4,883(45,419)
Total current assets:115,228178,778244,291347,554419,802
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization     83
Operating lease, right-of-use asset3,17619,65724,70726,90427,322
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization3,82110,25212,985  
Long-term investments and receivables  1,9899,762 49,001
Long-term investments  1,9899,762 49,001
Restricted cash and investments2,0262,0262,0262,0262,027
Other noncurrent assets1125771,167112166
Other undisclosed noncurrent assets    14,88013,563
Total noncurrent assets:9,13534,50150,64743,92292,162
TOTAL ASSETS:124,363213,279294,938391,476511,964
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,01911,81418,01010,0619,524
Accounts payable2,4028835,0479984,550
Accrued liabilities7,61710,93112,9639,0634,974
Deferred revenue 1,8649,584   
Restructuring reserve     
Other liabilities  4041,1291,4562,395
Other undisclosed current liabilities3,3942,8932,3472,109937
Total current liabilities:15,27724,69521,48613,62612,856
Noncurrent Liabilities
Long-term debt and lease obligation:    31,65331,120
Liabilities, other than long-term debt21,50629,50628,9531,1002,469
Deferred revenue  4,127   
Other liabilities   2091,1002,469
Operating lease, liability21,50625,37928,74431,65331,120
Total noncurrent liabilities:21,50629,50628,95332,75333,589
Total liabilities:36,78354,20150,43946,37946,445
Equity
Equity, attributable to parent87,580159,078244,499345,097465,519
Common stock6059575654
Additional paid in capital682,451667,861641,422608,064577,390
Accumulated other comprehensive income (loss) 919(792)(39)(19)
Accumulated deficit(594,940)(508,861)(396,188)(262,984)(111,906)
Total equity:87,580159,078244,499345,097465,519
TOTAL LIABILITIES AND EQUITY:124,363213,279294,938391,476511,964

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues9,8486,288   
Gross profit:9,8486,288   
Operating expenses(102,735)(128,118)(137,115)(151,398)(58,044)
Operating loss:(92,887)(121,830)(137,115)(151,398)(58,044)
Nonoperating income (expense)6,8089,1573,911320(30,400)
Investment income, nonoperating6,8089,1573,911320898
Interest and debt expense     (3,890)
Loss from continuing operations:(86,079)(112,673)(133,204)(151,078)(92,334)
Loss before gain (loss) on sale of properties:✕✕✕✕(151,078)(92,334)
Net loss:(86,079)(112,673)(133,204)(151,078)(92,334)
Other undisclosed net income attributable to parent     3,890
Net loss available to common stockholders, diluted:(86,079)(112,673)(133,204)(151,078)(88,444)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(86,079)(112,673)(133,204)(151,078)(92,334)
Comprehensive loss:(86,079)(112,673)(133,204)(151,078)(92,334)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(10)811(753)(20)3,889
Comprehensive loss, net of tax, attributable to parent:(86,089)(111,862)(133,957)(151,098)(88,445)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: